180 related articles for article (PubMed ID: 24944508)
1. Optimization of biguanide derivatives as selective antitumor agents blocking adaptive stress responses in the tumor microenvironment.
Narise K; Okuda K; Enomoto Y; Hirayama T; Nagasawa H
Drug Des Devel Ther; 2014; 8():701-17. PubMed ID: 24944508
[TBL] [Abstract][Full Text] [Related]
2. Development of antitumor biguanides targeting energy metabolism and stress responses in the tumor microenvironment.
Sakai T; Matsuo Y; Okuda K; Hirota K; Tsuji M; Hirayama T; Nagasawa H
Sci Rep; 2021 Mar; 11(1):4852. PubMed ID: 33649449
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of novel benzylidene-succinimide derivatives as noncytotoxic antiangiogenic inhibitors with anticolorectal cancer activity in vivo.
Luo K; Bao Y; Liu F; Xiao C; Li K; Zhang C; Huang R; Lin J; Zhang J; Jin Y
Eur J Med Chem; 2019 Oct; 179():805-827. PubMed ID: 31295714
[TBL] [Abstract][Full Text] [Related]
4. Ring-truncated deguelin derivatives as potent Hypoxia Inducible Factor-1α (HIF-1α) inhibitors.
Kim HS; Hong M; Lee SC; Lee HY; Suh YG; Oh DC; Seo JH; Choi H; Kim JY; Kim KW; Kim JH; Kim J; Kim YM; Park SJ; Park HJ; Lee J
Eur J Med Chem; 2015 Nov; 104():157-64. PubMed ID: 26457742
[TBL] [Abstract][Full Text] [Related]
5. Quinazoline-based multi-tyrosine kinase inhibitors: synthesis, modeling, antitumor and antiangiogenic properties.
Conconi MT; Marzaro G; Urbani L; Zanusso I; Di Liddo R; Castagliuolo I; Brun P; Tonus F; Ferrarese A; Guiotto A; Chilin A
Eur J Med Chem; 2013 Sep; 67():373-83. PubMed ID: 23900004
[TBL] [Abstract][Full Text] [Related]
6. Novel chalcone derivatives as hypoxia-inducible factor (HIF)-1 inhibitor: synthesis, anti-invasive and anti-angiogenic properties.
Wang L; Chen G; Lu X; Wang S; Han S; Li Y; Ping G; Jiang X; Li H; Yang J; Wu C
Eur J Med Chem; 2015 Jan; 89():88-97. PubMed ID: 25462229
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of 3-(phenylethynyl)-1,1'-biphenyl-2-carboxylate derivatives as new HIF-1 inhibitors.
Wang S; Wang X; Shao Y; Shao K; Wang Y; Guo X; Dong H; Zhao W; Li Y; Li G
Bioorg Chem; 2021 Nov; 116():105298. PubMed ID: 34454298
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis of novel celastrol derivatives and study on their antitumor growth through HIF-1α pathway.
Shang FF; Wang JY; Xu Q; Deng H; Guo HY; Jin X; Li X; Shen QK; Quan ZS
Eur J Med Chem; 2021 Aug; 220():113474. PubMed ID: 33930802
[TBL] [Abstract][Full Text] [Related]
9. Molecular and functional evaluation of a novel HIF inhibitor, benzopyranyl 1,2,3-triazole compound.
Park K; Lee HE; Lee SH; Lee D; Lee T; Lee YM
Oncotarget; 2017 Jan; 8(5):7801-7813. PubMed ID: 27999195
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and structure-activity relationships of asymmetric dimeric β-carboline derivatives as potential antitumor agents.
Guo L; Chen W; Cao R; Fan W; Ma Q; Zhang J; Dai B
Eur J Med Chem; 2018 Mar; 147():253-265. PubMed ID: 29448140
[TBL] [Abstract][Full Text] [Related]
11. 6-Amino-2,4,5-trimethylpyridin-3-ols: a new general synthetic route and antiangiogenic activity.
Kim DG; Kang Y; Lee H; Lee EK; Nam TG; Kim JA; Jeong BS
Eur J Med Chem; 2014 May; 78():126-39. PubMed ID: 24681390
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and antiangiogenic activity of 6-amido-2,4,5-trimethylpyridin-3-ols.
Lee H; Banskota S; Kim DG; Been JH; Jin YJ; Gautam J; Jang H; Nam TG; Kim JA; Jeong BS
Bioorg Med Chem Lett; 2014 Jul; 24(14):3131-6. PubMed ID: 24894557
[TBL] [Abstract][Full Text] [Related]
13. Anticancer imidazoacridinone C-1311 inhibits hypoxia-inducible factor-1α (HIF-1α), vascular endothelial growth factor (VEGF) and angiogenesis.
Paradziej-Łukowicz J; Skwarska A; Peszyńska-Sularz G; Brillowska-Dąbrowska A; Konopa J
Cancer Biol Ther; 2011 Oct; 12(7):586-97. PubMed ID: 21775820
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, Anticancer Activities, and Mechanism of N-heptyl-containing Biguanide Derivatives.
Wang W; Xiao D; Zhou S; Xu S; Tang X; Zhou X; Liu J; Xu C; Peng M; Yang X
Med Chem; 2022; 18(8):895-902. PubMed ID: 35142271
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of novel N
Guo L; Ma Q; Chen W; Fan W; Zhang J; Dai B
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):375-387. PubMed ID: 30734606
[TBL] [Abstract][Full Text] [Related]
16. Identification of novel antiangiogenic anticancer activities of deguelin targeting hypoxia-inducible factor-1 alpha.
Oh SH; Woo JK; Jin Q; Kang HJ; Jeong JW; Kim KW; Hong WK; Lee HY
Int J Cancer; 2008 Jan; 122(1):5-14. PubMed ID: 17764071
[TBL] [Abstract][Full Text] [Related]
17. Discovery of derivatives of 6(7)-amino-3-phenylquinoxaline-2-carbonitrile 1,4-dioxides: novel, hypoxia-selective HIF-1α inhibitors with strong antiestrogenic potency.
Buravchenko GI; Scherbakov AM; Dezhenkova LG; Bykov EE; Solovieva SE; Korlukov AA; Sorokin DV; Monzote Fidalgo L; Shchekotikhin AE
Bioorg Chem; 2020 Nov; 104():104324. PubMed ID: 33142432
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of C-ring truncated deguelin derivatives as heat shock protein 90 (HSP90) inhibitors.
Kim HS; Hong M; Ann J; Yoon S; Nguyen CT; Lee SC; Lee HY; Suh YG; Seo JH; Choi H; Kim JY; Kim KW; Kim J; Kim YM; Park SJ; Park HJ; Lee J
Bioorg Med Chem; 2016 Nov; 24(22):6082-6093. PubMed ID: 27745993
[TBL] [Abstract][Full Text] [Related]
19. A novel inhibitor of hypoxia-inducible factor-1α P3155 also modulates PI3K pathway and inhibits growth of prostate cancer cells.
Manohar SM; Padgaonkar AA; Jalota-Badhwar A; Sonawane V; Rathos MJ; Kumar S; Joshi KS
BMC Cancer; 2011 Aug; 11():338. PubMed ID: 21819554
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and target identification of new hypoxia-inducible factor 1 (HIF-1) inhibitors containing 1-alkyl-1H-pyrazole-3-carboxamide moiety.
Sakai M; Takahashi N; Ikeda H; Furutani Y; Higuchi S; Suzuki T; Dohmae N; Kobayashi S; Harada H; Kojima S; Matsuura T; Hattori A; Kakeya H
Bioorg Med Chem; 2021 Sep; 46():116375. PubMed ID: 34492592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
